Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant

Transfusion

Volumn 50, Issue 2, 2010, Pages 501-506

  Picardi, Alessandra ^a,b   Lanti, Alessandro ^a,b   Cudillo, Laura ^a,b   Cerretti, Raffaella ^a,b   Dentamaro, Teresa ^a,b   De Angelis, Gottardo ^a,b   Ferraro, Angelo ^a,b   Di Veroli, Ambra ^a,b   Adorno, Gaspare ^a,b   Arcese, William ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FIBRIN; FIBRIN GLUE; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOMATION; CLINICAL ARTICLE; DEVICE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MUCOSAL DISEASE; SKIN DEFECT; THROMBOCYTE; TREATMENT OUTCOME;

ADULT; AUTOMATION; BIOLOGICAL PRODUCTS; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; FEMALE; FIBRIN TISSUE ADHESIVE; GELS; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ORAL ULCER; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT PROJECTS; REGENERATION; SKIN ULCER; TISSUE ADHESIVES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 75749112071     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02439.x     Document Type: Article

References (20)

1. Hakan Goker I, Haznedaroglu C, Nelson JC. Acute graft-vs-host disease: pathobiology and management. Exp Hematol 2001 29 : 259 77.
2. Bacigalupo A. Management of acute graft-versus-host disease. BrJ Haematol 2007 137 : 87 98.
3. Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G. Prospective evaluation of 2 acute graft versus host disease (GVHD) grading systems: a Joint Societe Française de Moelle et Therapie Cellulaire, Dana Farber Cancer Institute and International Bone Marrow Registry (IBMTR) prospective study. Blood 2005 106 : 1495 500.
4. Cutler C, Giri S, Jeyepalan S, Paniagua D, Viswanathen A, Antin JH. Acute and chronic graft versus host disease after allogeneic peripheral blood stem cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001 19 : 3685 91.
5. Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 101 : 175 83.
6. Couriel DR. Ancillary and supportive care in chronic graft versus host disease. Best Pract Res Clin Haematol 2008 21 : 291 307.
7. Tarroni G, Tessarin C, De Silvestro L, Casol D, Giozzet M, Caloprisco G, De Paoli Vitali E. Local therapy with platelet-derived growth factors for chronic diabetic ulcers in haemodialysis patients. G Ital Nefrol 2002 19 : 630 3.
8. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Moroni M, Carabelli A. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 2004 30 : 145 51.
9. Sanford JS, Kashiwagi H, Nisar P. Integrin signaling: the platelet paradigm. Blood 1998 91 : 2645 57.
10. Verheul MW, Jorna A, Hoekman K, Broxterman J, Gebbink MF, Pinedo H. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 2000 96 : 4216 21.
11. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004 44 : 1013 8.
12. Rajkumar VS, Shiwen X, Bostrom M, Leoni P, Muddle J, Ivarsson M, Gerdin B, Denton CP, Bou-Gharios G, Black CM, Abraham DJ. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 2006 169 : 2254 65.
13. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974 18 : 295 304.
14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995 15 : 825 8.
15. Shulman HM, Sullivan KM, Weiden PL, Mc Donald GB, Striker GE, Hackman R, Tsoi MS, Storb R, Thomas ED. Chronic graft vs host syndrome in man. A long term clinocopathologic study of 20 Seattle patients. Am J Med 1980 69 : 204 17.
16. Velada JL, Holingsbee DA. Physical characteristics of Vivostat® patient-derived sealant. Eur Surg Res 2001 33 : 399 404.
17. Smith RG. Validation of Wagner's classification: a literature review. Ostomy Wound Manage 2003 49 : 54 62.
18. Davis BR, Sándor GK. Use of fibrin glue in maxillofacial surgery. J Otolaryngol 1998 27 : 107 12.
19. Matsuo R, Ohkohchi N, Murata S, Ikeda O, Nakano Y, Watanabe M, Hisakura K, Myronovych A, Kubota T, Narimatsu H, Ozaki M. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res 2008 145 : 279 86.
20. Tirindelli MC, Flammia G, Sergi F, Cerretti R, Cudillo L, Picardi A, Postorino M, Annibali O, Greco R, Avvisati G, Arcese W. Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood and haploidentical hematopoietic stem cell transplantation. Transfusion 2009 49 : 170 5.